CANCELLED - SECTION 8
section 8
on 31 Jul 2004
Last Applicant/ Owned by
8 King Street East, Suite 1300
Toronto, Ontario
CA
M5C 1B5
Serial Number
74593428 filed on 01st Nov 1994
Registration Number
2108093 registered on 28th Oct 1997
Correspondent Address
IVOR M. HUGHES
Filing Basis
No Filing Basis
Disclaimer
NO DATA
"HIT"
pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elimin Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
licensing the intellectual property technology regarding pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of medical conditions and disease in humans
Class [005]
Pharmaceutical Products
pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elimination of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification; bronchodilation; vascular ischemia; HIV (AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthitis or pannus; cancer tumours; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratoses; liver spots; squamous cell tumours; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumour of the skin; genital warts (condyloma acuminata); cervical cancer; Human Papilloma Virus (HPV); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infilitration
Mark Details
Serial Number
No 74593428
Mark Type
No Service Mark
Attorney Docket Number
No TM.1788
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Jul 2004 | CANCELLED SEC. 8 (6-YR) |
| 28th Oct 1997 | REGISTERED-PRINCIPAL REGISTER |
| 05th Aug 1997 | PUBLISHED FOR OPPOSITION |
| 04th Jul 1997 | NOTICE OF PUBLICATION |
| 19th May 1997 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 02th Apr 1997 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 08th Feb 1997 | FINAL REFUSAL MAILED |
| 03rd Dec 1996 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 06th Jun 1996 | UNRESPONSIVE/DUPLICATE PAPER RECEIVED |
| 04th Jun 1996 | INQUIRY AS TO SUSPENSION MAILED |